QIAGEN announced it has entered into a definitive agreement to acquire Parse Biosciences, a pioneer in scalable, instrument-free single-cell sequencing solutions, marking a major...
Parse Biosciences, the leader in scalable single-cell sequencing solutions, announced the expansion of its Evercode BCR product line to support applications in mice. The...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been certified as the latest member...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced the availability of Evercode™ BCR and the expansion of its...
